1 AI Stock to Buy Before Its Revenue Accelerates in the Back Half of 2026

Salesforce says AI-related revenue from Agentforce and Data 360 reached $3.4 billion in annual recurring revenue, up more than 200% year over year, with Agentforce alone passing a $1 billion run rate. Management expects revenue growth to reaccelerate from 10% to 11% in the first half of the year toward the second half of fiscal 2027 and reaffirmed FY2027 revenue guidance of $45.9 billion to $46.2 billion. The company also authorized a $27 billion accelerated share repurchase, reinforcing confidence in the outlook.

Analysis

The market is still pricing CRM like a mature seat-license company, but the mix shift toward AI workflow monetization changes the multiple equation. If AI-linked products are becoming the largest driver of incremental dollars, the relevant debate is no longer revenue growth alone; it is whether CRM can convert a low-visibility product cycle into a durable attach-rate expansion story that supports both margin and free cash flow leverage. That matters because the stock can re-rate before the P&L fully reflects the improvement, especially once customers move from pilot usage to enterprise-wide deployment.

The biggest second-order effect is competitive pressure on adjacent enterprise software vendors. CRM’s ability to bundle AI into a broad customer base raises the hurdle for point-solution AI startups and weakens the pricing power of smaller SaaS peers that lack distribution. It also creates a spillover benefit for infrastructure names tied to training, inference, and data integration, but with a catch: the more CRM proves AI can be sold into a huge installed base, the more investors will ask which incumbents are next, compressing the premium once reserved for pure-play AI software.

The main risk is timing, not thesis. Management’s guide implies a back-half acceleration that leaves a multi-quarter window where valuation can stay pinned if execution slips even modestly on conversion rates, implementation cycles, or budget scrutiny. The market will likely tolerate slower headline growth only if current RPO and AI ARR continue compounding; a deceleration there would quickly unwind the buyback-supported floor.

The contrarian read is that the easy upside may already be in the stock, but the downside is more protected than consensus assumes because the company is effectively buying back a meaningful amount of float while AI monetization is still in early innings. In other words, this is less a clean growth story than a self-help + re-rating setup. If the next two quarters confirm that AI is expanding deal size rather than just re-labeling existing spend, the market may have to move from discounting CRM as software to valuing it as an AI-enabled platform with recurring monetization power.

Key Decisions for Investors

• Long CRM on a 3-6 month horizon; size for a 15-20% upside case if AI attach rates and backlog conversion stay on track, with downside likely capped by buybacks and low-teens earnings multiple support.
• Buy CRM Jan-2027 call spreads to express the back-half acceleration thesis; structure for limited premium outlay and upside if the market starts pricing fiscal-2027 growth re-acceleration before reported revenue inflects.
• Pair long CRM / short a basket of lower-quality SaaS names with weaker AI monetization visibility over the next 1-2 quarters; the trade benefits if investors differentiate platform winners from implementation laggards.
• Add INFA as a smaller strategic long only on pullbacks; the acquisition link makes it a cleaner AI data-enablement expression, but the position should be sized below CRM because the upside is more takeout- and integration-dependent.
• Avoid chasing the trade after strong AI ARR headlines; the better entry is on any post-earnings consolidation, where buyback support can absorb technical selling while the next catalyst window remains intact.